Literature DB >> 17338859

The impact of viral and host elements on HIV fitness and disease progression.

Kenneth R Henry1, Jan Weber, Miguel E Quiñones-Mateu, Eric J Arts.   

Abstract

Twenty-five years after the emergence of HIV onto the global scene, multiple advancements have been made in the understanding of HIV pathology. Thanks to the development of antiretroviral therapies, growing numbers of individuals with HIV infection experience slowed or halted acceleration to AIDS. Despite this, new HIV infections and AIDS-related morbidity and mortality are still common in the highly active antiretroviral therapy era. Recently, we and others have identified viral replicative fitness as a major determinant of HIV disease progression, which could have a major impact in the clinical setting. Therefore, in this review, we will discuss host and viral factors that affect viral fitness and its relationship on HIV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17338859     DOI: 10.1007/s11904-007-0006-9

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  71 in total

Review 1.  Pathogenesis of simian immunodeficiency virus infection.

Authors:  L E Whetter; I C Ojukwu; F J Novembre; S Dewhurst
Journal:  J Gen Virol       Date:  1999-07       Impact factor: 3.891

Review 2.  The role of dendritic cell C-type lectin receptors in HIV pathogenesis.

Authors:  Stuart Turville; John Wilkinson; Paul Cameron; Joanne Dable; Anthony L Cunningham
Journal:  J Leukoc Biol       Date:  2003-09-02       Impact factor: 4.962

3.  Founder virus population related to route of virus transmission: a determinant of intrahost human immunodeficiency virus type 1 evolution?

Authors:  V V Lukashov; J Goudsmit
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.

Authors:  V S Torre; A J Marozsan; J L Albright; K R Collins; O Hartley; R E Offord; M E Quiñones-Mateu; E J Arts
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

6.  HIV-1 dynamics in vivo.

Authors:  D D Ho
Journal:  J Biol Regul Homeost Agents       Date:  1995 Jul-Sep       Impact factor: 1.711

7.  Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.

Authors:  D E Mosier; G R Picchio; R J Gulizia; R Sabbe; P Poignard; L Picard; R E Offord; D A Thompson; J Wilken
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

8.  Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry.

Authors:  Andre J Marozsan; Dawn M Moore; Michael A Lobritz; Erika Fraundorf; Awet Abraha; Jacqueline D Reeves; Eric J Arts
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

9.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

View more
  3 in total

1.  HIV-1 reverse transcriptase dissociates during strand transfer.

Authors:  John M Muchiri; Sean T Rigby; Laura A Nguyen; Baek Kim; Robert A Bambara
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

2.  Role of co-expressed APOBEC3F and APOBEC3G in inducing HIV-1 drug resistance.

Authors:  Nazanin Mohammadzadeh; Robin P Love; Richard Gibson; Eric J Arts; Art F Y Poon; Linda Chelico
Journal:  Heliyon       Date:  2019-04-16

Review 3.  Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses.

Authors:  Amit Gaba; Ben Flath; Linda Chelico
Journal:  Viruses       Date:  2021-06-07       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.